Desenvolvimento de sistema para acompanhamento e geração de protocolos de estimulação elétrica nervosa transcutânea

Abstract

Defines Neurogenic Bladder as a dysfunction of the lower urinary tract resul- ting from congenital or acquired lesions in the nervous system, both at the central and peripheral levels. As a result, individuals with this condition may experience deterioration of the upper urinary tract, which can lead to kidney failure or even death of the individual in more advanced stages. In order to improve the quality of life of these individuals, transcutaneous electrical neurostimulation (TENS) is used, which consists of providing electrical current through electrodes on the skin and modulating bladder innervation, and consequently treating the neurogenic bladder.However, commercial neurostimulators for the treatment of neurogenic bladder are expensive and do not offer the option of adjusting stimulation para- meters, which makes it difficult to customize therapy for each individual. As well as for proper monitoring for home use. Therefore, the objective of the project is to develop a low-cost neuromodulation system with greater functionality in the adjustment of stimulation parameters for use in the treatment of neurogenic blad- der. Developed information visualization in Django integrated into a database. It also uses a library to make communication with IoT devices transparent to the web service. The system is divided into six modules: (i) Administrator interface that allows the registration of the health professional, as well as the registration of the patient. (ii) Patient’s medical record registration interface. (iii) IoT devices integration and configuration interface. (iv) Registration of stimulation protocol. (V) Session Setup (vi) Therapy Supervision. The results show that the system is functional when performing operations with the database. The functionality tests with devices showed that it is possible to perform data transmission simultane- ously with three devices. Despite the limitations presented, it is expected that the equipment developed will be safe and effective for performing transcutaneous neuromodulation. Furthermore, it could revolutionize the management of neuro- genic bladder, making neuromodulation therapy accessible to low-income users and made available by the public health system at a reduced cost to public coffers.